Log in to search using one of your social media accounts:

 

MassDevice.com +5 | The top 5 medtech stories for August 23, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Microinnovation: what paper towels have to teach us about medtech How can you double the efficiency of a paper towel? Turns out you don’t need to reformulate or make the paper thicker. Instead, you find a simple concept t...
Source: Mass Device - August 23, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Centurion Labs Issues Voluntary Nationwide Recall of Ninjacof (Lot # 200N1601) and Ninjacof A (Lot# 201NA1601) Products Due to Potential < em > Burkholderia Cepacia < /em > Contamination
Centurion Labs is voluntarily recalling, as a precautionary measure, 1 lot of Ninjacof (Lot# 200N1601) and 1 lot of Ninjacof A (Lot# 201NA1601) manufactured by Vilvet (Dania Beach, FL) and distributed by Centurion Labs to the retail level due to potential contamination with Burkholderia cepacia. Centurion was notified by the FDA regarding the potential contamination as they discovered this product may have been manufactured in a Pharmatech, FDA registered facility, in Davie, FL. that was found to have a product that contained B. cepacia. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 23, 2017 Category: Food Science Source Type: news

Stryker slips on Sage Products recall
Stryker (NYSE:SYK) shares slipped today after the medical device company said it’s recalling some of the products sold by subsidiary Sage Products and narrowed its outlook for the rest of the year. Kalamazoo, Mich.-based Stryker paid $2.7 billion in April 2016 for Sage and its line of products designed to prevent so-called “never events.” But it wasn’t long before problems emerged with some of those products; by August Sage had expanded an existing recall of impregnated cloth topical skin products over contamination issues with the bacteria Burkholderia cepacia. That recall covered the Comfort ...
Source: Mass Device - August 23, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Hospital Care Recalls Regulatory/Compliance Sage Products Stryker Source Type: news

FDA warns of potential contamination in multiple brands of drugs, dietary supplements
The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 11, 2017 Category: American Health Source Type: news

FDA Warns Against Use of Any Liquid Product From PharmaTech FDA Warns Against Use of Any Liquid Product From PharmaTech
Lab tests have found Burkholderia cepacia contamination in PharmaTech's oral liquid docusate products, which has been linked to recent patient infections.News Alerts (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - August 9, 2017 Category: Intensive Care Tags: Infectious Diseases News Alert Source Type: news

Rugby Laboratories Issues Voluntary Nationwide Recall of Diocto Liquid and Diocto Syrup Manufactured By PharmaTech, LLC Due to Possible Product Contamination
Rugby ® Laboratories of Livonia, MI is voluntarily recalling all lots within the expiry of Diocto Liquid and Diocto Syrup, (docusate sodium solutions) manufactured by PharmaTech, LLC of Davie, FL due to a risk of product contamination with Burkholderia cepacia. If a product contains B. cepacia, its use c ould result in infections in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis. Some of these infections may be serious or even life-threatening in the at-risk patient population. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 3, 2017 Category: Food Science Source Type: news

Synspira ’s therapy could boost antibiotics against drug-resistant bacteria in CF patients
Privately-held Synspira touted a study today of its inhaled glycopolymer-based therapeutic with antibiotics as a potential treatment for pulmonary infection caused by the Burkholderia cepacia complex in patients with cystic fibrosis. The study was published in PLOS One. Synspira’s lead polycationic glycopolymer, SNSP113, was studied in combination with tobramycin and meropenem. These antibiotics, as well as ceftazidime, are often used to treat Bcc infections in patients with cystic fibrosis. However, Synspira said the microbial agents have demonstrated limited efficacy in the past. Get t...
Source: Mass Device - July 12, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Research & Development Respiratory synspira Source Type: news

Symbiotic bacteria: From hitchhiker to beetle bodyguard
Bacterial symbionts transition between plant pathogenicity and insect defensive mutualism, a new report demonstrates. The bacterium Burkholderia gladioli lives in specific organs of a plant-feeding beetle and defends the insect's eggs from detrimental fungi by producing antibiotics. However, when transferred to a plant, the bacterium can spread throughout the tissues and negatively affect the plant. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 28, 2017 Category: Science Source Type: news

Symbiotic bacteria: From hitchhiker to beetle bodyguard
(Johannes Gutenberg Universitaet Mainz) An international team of researchers have discovered a remarkable microbe with a Jekyll and Hyde character. The bacterium Burkholderia gladioli lives in specific organs of a plant-feeding beetle and defends the insect's eggs from detrimental fungi by producing antibiotics. However, when transferred to a plant, the bacterium can spread throughout the tissues and negatively affect the plant. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 28, 2017 Category: Biology Source Type: news

Master switch turns on silent biosynthetic gene clusters
Scientists have discovered a global regulator in the model bacterium Burkholderia thailandensis that'switches on'many silent clusters at once, unleashing their full ability to make possible drug candidate natural products. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 13, 2017 Category: Science Source Type: news

Scientists discover master switch to turn on silent biosynthetic gene clusters
(Princeton University) Scientists at Princeton University have discovered a global regulator in the model bacterium Burkholderia thailandensis that 'switches on' many silent clusters at once, unleashing their full ability to make possible drug candidate natural products. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 13, 2017 Category: Global & Universal Source Type: news

From Genome Research: Pathogen demonstrates genome flexibility in cystic fibrosis
(Cold Spring Harbor Laboratory) Chronic lung infections can be devastating for patients with cystic fibrosis (CF), and infection by Burkholderia cenocepacia, one of the most common species found in cystic fibrosis patients, is often antibiotic resistant. In a study published today in Genome Research, scientists sequenced and phenotyped multiple B. cenocepacia isolates from 16 CF patients. They found extensive variation among isolates during chronic lung infection as well as changes in clinically relevant bacterial phenotypes. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 21, 2017 Category: Infectious Diseases Source Type: news

Infectious outbreak in critically ill children leads to recall of contaminated medication
Infection prevention and control experts halted a 24-patient outbreak of Burkholderia cepacia in critically ill children after identifying docusate, a liquid stool softener, as the underlying source of the bacteria. Details of the six-month investigation led to a national recall of all liquid products manufactured by PharmTech. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 9, 2017 Category: Science Source Type: news

Infectious outbreak in critically ill children leads to recall of contaminated medication
(Society for Healthcare Epidemiology of America) Infection prevention and control experts at Texas Children's Hospital halted a 24-patient outbreak of Burkholderia cepacia in critically ill children after identifying docusate, a liquid stool softener, as the underlying source of the bacteria. Details of the six-month investigation, published online in Infection Control& Hospital Epidemiology, the journal for the Society for Healthcare Epidemiology of America, led to a national recall of all liquid products manufactured by PharmTech. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 9, 2017 Category: Infectious Diseases Source Type: news

Class I Medical Device Recall: Nurse Assist Inc. Recalls Normal Saline Flush IV Syringes Due to Possible Burkholderia Cepacia Bloodstream Infections
Nurse Assist Inc. is recalling the normal saline flush syringes due to incidents of Burkholderia cepacia (B. cepacia) contamination. B. cepacia is a bacterium that can cause bloodstream infections, particularly in patients with weak immune systems. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - January 3, 2017 Category: Medical Equipment Source Type: news

Stryker ’ s Sage Products invests $3.4m to expand HQ
Stryker (NYSE:SYK) subsidiary Sage Products purchased 27 acres of land in Cary, Ill. for $3.4 million, looking to expand its headquarters in the area, according to a Daily Herald report. Sage makes products for oral care, skin preparation & protection, patient cleaning & hygiene, turning & positioning and heel care. The planned expansion includes an 810,000 square foot addition to the facilities, and is slated to add an additional 350 jobs by 2021, according to the report. Stryker closed its $2.7 billion acquisition of Sage Products in April. The deal for Sage Products, which makes...
Source: Mass Device - December 19, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Sage Products Stryker Source Type: news

An Unusual case of Burkholderia dolosa Infection in a Cystic Fibrosis Patient but Not His Sister
Irreversible decline in lung function is one of the key contributors to mortality and morbidity in the cystic fibrosis (CF) population [1]. One key determinant of lung health is recurrent respiratory infections with opportunistic pathogens. Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans, Haemophilus influenzae, non-tuberculous mycobacteria, Staphylococcus aureus, Aspergillus fumigatus, and Burkholderia cepacia complex (BCC) are common opportunistic agents of infections or chronic pulmonary colonizers in the CF population [1]. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - November 19, 2016 Category: Microbiology Authors: Grace Y. Lam, Josette Salgado, Jamil Kanji, James E.A. Zlosnik, Neil E. Brown, Winnie M. Leung Tags: Case Report Source Type: news

In South Jersey, 13 sick with bacterial infection linked to contaminated syringes
Pre-filled syringes produced by a Texas-based medical device manufacturer are linked to 13 new cases of a bacterial infection in New Jersey, where several dozen people have already been affected. The 13 new cases, 10 in Atlantic County and three in Ocean County, come five weeks after Halton City, Texas-based Nurse Assist voluntarily recalled all of its I.V. flush syringes "due to a potential link to Burkholderia cepacia bloodstream infections with the product," according to the FDA. The v oluntary… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 14, 2016 Category: Pharmaceuticals Source Type: news

Nurse Assist Initiates Nationwide Voluntary Recall of All Unexpired Lots of I.V. Flush Syringes
Nurse Assist, Inc. announced today that it is voluntarily recalling all unexpired lots of I.V. Flush Syringes due to a potential link to Burkholderia cepacia bloodstream infections with the product.  According to the U.S. Centers for Disease Control and Prevention (CDC), the effects of Burkholderia cepacia on people'vary widely, ranging from no symptoms at all to serious respiratory infections, especially in patients with cystic fibrosis.' If a patient is having symptoms, contact your health care provider. (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 5, 2016 Category: Food Science Source Type: news

USFDA slaps ban on API supplied by India ’s Laxachem
The USFDA has banned products of Laxachem Organics, a maker of active pharmaceutical ingredients, from US markets as part of the effort to arrest the Burkholderia cepacia or the B Cepacia infection (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 20, 2016 Category: Pharmaceuticals Source Type: news

Health Canada recalls Sage Product cleansing cloths
A line of disposable cleansing cloths commonly used in hospitals across the country has been recalled by the company due to possible Burkholderia cepacia contamination. (Source: CBC | Health)
Source: CBC | Health - September 8, 2016 Category: Consumer Health News Tags: News/Canada/Nova Scotia Source Type: news

Burkholderia cepacia: a Complex Problem for More than Cystic Fibrosis Patients
It is always surprising to find that an organism we know only from the clinical laboratory is a “player” in other venues. Therefore, it was with some fascination that we learned that Burkholderia cepacia, long known as a pathogen in cystic fibrosis patients, is also the number one organism isolated from product recalls. We recount the story of this amazing organism, which has a place in th e clinical, agricultural, and pharmaceutical sectors. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - September 3, 2016 Category: Microbiology Authors: Nehemiah J. Landes, Hannah N. Livesay, Fran Schaeffer, Pam Terry, Ernest Trevino, Alice Schauer Weissfeld Source Type: news

Stryker ’ s Sage Products expands med wipes recall over B. cepacia contamination concerns
Stryker‘s (NYSE:SYK) Sage Products subsidiary is expanding its voluntary worldwide recall to include lots of impregnated cloth topical skin products over contamination issues with the bacteria Burkholderia cepacia, according to an FDA notice. The recall includes Sage Products’ Comfort Shield barrier cloths, incontinence clean-up cloths, M-care meatal cleansing cloths, Comfort Bath cleansing washcloths and .2% chlorhexidine gluconate cloths. Use of the products contaminated with B. cepacia could cause serious infections in patients with compromised immune systems or in hospitalized patients which could be life t...
Source: Mass Device - August 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Food & Drug Administration (FDA) Hospital Care Recalls Sage Products Stryker Source Type: news

Sage Products Expands Voluntary Worldwide Recall of Specific Lots of Topical Skin Products Due to Potential Microbial Contamination - Second Expansion
Sage Products announced today it is expanding its voluntary worldwide recall to include specific lots of impregnated cloth topical skin products at the distributor, healthcare facility, retail and consumer/user levels. The recall is being initiated due to potential product contamination with the bacteria, Burkholderia cepacia. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 22, 2016 Category: Food Science Source Type: news

Sage Products Expands Voluntary Nationwide Recall of Comfort Shield Barrier Cream Cloths Due to Microbial Contamination
Cary, IL, Sage Products announced today it is expanding its voluntary nationwide recall to include an additional lot of Comfort Shield Barrier Cream Cloths at the distributor and healthcare facility/user level. The recall is being initiated due to product contamination with the bacteria, Burkholderia cepacia. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 17, 2016 Category: Food Science Source Type: news

PharmaTech Recalls All Liquid Products
Florida-based PharmaTech LLC is voluntarily recalling all liquid products dated from October 20, 2015 through July 15, 2016 as a precautionary measure due to a potential risk of product contamination with Burkholderia cepacia. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 9, 2016 Category: Pharmaceuticals Source Type: news

More Liquid Products Recalled During B. cepacia Outbreak (FREE)
By the Editors PharmaTec, LLC is recalling all of its liquid products over concerns that they may be contaminated with Burkholderia cepacia, … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 9, 2016 Category: Primary Care Source Type: news

PharmaTech LLC Issues Voluntary Nationwide Recall Due to Potential Risk of Product Contamination
PharmaTech, LLC of Davie, FL, is voluntarily recalling all liquid products from October 20, 2015 through July 15, 2016 as a precautionary measure due to a potential risk of product contamination with Burkholderia cepacia.If a product contains B. cepacia, its use could result in infections in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis. Some of these infections may be serious or even life-threatening in the at risk patient population. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 9, 2016 Category: Food Science Source Type: news

Contaminated Comfort Shield Barrier Cream Cloths Recalled Contaminated Comfort Shield Barrier Cream Cloths Recalled
Comfort Shield Barrier Cream Cloths have been recalled by Sage Products because they may be contaminated with Burkholderia cepacia.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 3, 2016 Category: Consumer Health News Tags: Nursing News Alert Source Type: news

Sage Products Issues Voluntary Nationwide Recall of Comfort Shield Barrier Cream Cloths Due to Microbial Contamination
CARY, Ill., USA, July 29, 2016 /PRNewswire/ -- Sage Products announced today it is voluntarily initiating a nationwide recall of one lot of Comfort Shield Barrier Cream Cloths to the distributor and health care facility/user level. The recall is being initiated due to product contamination with the bacteria, Burkholderia cepacia. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 1, 2016 Category: Food Science Source Type: news

PharmaTech LLC Issues Voluntary Nationwide Recall of Diocto Liquid Distributed by Rugby Laboratories Due to Product Contamination
PharmaTech LLC of Davie, FL, the manufacturer of the Rugby®- branded product, is voluntarily recalling all lots within the expiry of Diocto Liquid, a docusate sodium solution due to a risk of product contamination with Burkholderia cepacia. Use of docusate sodium liquid contaminated with B. cepacia may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis. (Source: Food and Drug Administration)
Source: Food and Drug Administration - July 16, 2016 Category: Food Science Source Type: news

Don't Use Oral Liquid Docusate in Any Patient, CDC WarnsDon't Use Oral Liquid Docusate in Any Patient, CDC Warns
The advice comes as health officials continue to investigate a multistate outbreak of Burkholderia cepacia infections possibly linked to contaminated oral liquid docusate stool softener products. News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 11, 2016 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news

CDC Warns of Multistate Outbreak of Burkholderia cepacia Infection
The CDC and FDA have joined forces with various state and local health departments and health care facilities to investigate a multistate outbreak of Burkholderia cepacia infections. (Source: AAFP News)
Source: AAFP News - June 27, 2016 Category: Primary Care Source Type: news

Determination of the Persistence of Non-Spore-Forming Biological Threat Agents in the Environment
U.S. Environmental Protection Agency, Office of Research and Development, National Homeland Security Research Center. 12/07/2015This 35-page report presents the results of an investigation to evaluate the persistence (or natural attenuation) of Yersinia pestis (Y. pestis), Francisella tularensis (F. tularensis), and Burkholderia mallei (B. mallei) on glass and soil under multiple environmental conditions and time points. This generation of scientifically defensible persistence data is useful for the proper planning of decontamination efficacy tests and for formulation of response or remediation plans in preparation for pos...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 17, 2016 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

SURVEILLANCE SUMMARIES: Melioidosis Cases and Selected Reports of Occupational Exposures to Burkholderia pseudomallei — United States, 2008–2013
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 3, 2015 Category: American Health Source Type: news

Escape of dangerous bacterium leads to halt of risky studies at Tulane
Leak of Burkholderia pseudomallei has led to intense search for source, newspaper reports (Source: ScienceNOW)
Source: ScienceNOW - March 2, 2015 Category: Science Source Type: news

Baby Wipes Company Nutek Disposables Issues Recall After Possible Contamination
(Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - October 27, 2014 Category: Consumer Health News Source Type: news

Letter to the Editors
In the article entitled “Sniff the Plates? Laboratory Exposure to Burkholderia pseudomallei” in the February 15, 2013 issue of Clinical Microbiology Newsletter (CMN Vol. 35, No. 4), Knost et al. () reported a case of melioidosis in a 27-year-old-male. After reading the article, we note the need for a number of clarifications that we would like to bring to the attention of the CMN readership. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - April 28, 2014 Category: Microbiology Authors: Tina J. Benoit, David D. Blaney Tags: Letter to the Editors Source Type: news

Communication Between Bacteria Helps Them Resist Antibiotics
New research from Western University unravels a novel means of communication that allows bacteria such as Burkholderia cenocepacia (B. cenocepacia) to resist antibiotic treatment. B. cenocepacia is an environmental bacterium that causes devastating infections in patients with cystic fibrosis (CF) or with compromised immune systems. Dr. Miguel Valvano and first author Omar El-Halfawy, PhD candidate, show that the more antibiotic resistant cells within a bacterial population produce and share small molecules with less resistant cells, making them more resistant to antibiotic killing... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 6, 2013 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Bacteria communicate to help each other resist antibiotics
(University of Western Ontario) New research from Western University (Canada) unravels a novel means of communication that allows bacteria such as Burkholderia cenocepacia (B. cenocepacia) to resist antibiotic treatment. B. cenocepacia is an environmental bacterium that causes devastating infections in patients with cystic fibrosis. Dr. Miguel Valvano and first author Omar El-Halfawy, show that the more antibiotic resistant cells within a bacterial population produce and share small molecules with less resistant cells, making them more resistant to antibiotic killing. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 3, 2013 Category: Global & Universal Source Type: news

Sniff the Plates? Laboratory Exposure to Burkholderia pseudomallei
We report a case of melioidosis in a 27-year-old male who presented with localized neck swelling and later developed complications due to the patient's non-compliance with his antibiotic therapy. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - February 6, 2013 Category: Microbiology Authors: S. Knost, M.C. Marroum, T. Nozar, L. Tagle, J. Horton, L.W. Raymond, J. Kase, S. Kilpatrick, W. Boehringer, A.Y. Peng, R.L. Sautter Source Type: news

Zicam Extreme Congestion Relief Nasal Gel: Recall—Contamination With Burkholderia Cepacia
Matrixx Initiatives notified the public of a recall of one lot of Zicam Extreme Congestion Relief nasal gel. Burkholderia cepacia was found in a single sample of the product taken from the affected lot. The problem was detected during a routine review at the manufacturing facility. Tests on additional samples from the same lot have shown no evidence of the organism. (Source: NCCAM Featured Content)
Source: NCCAM Featured Content - December 19, 2012 Category: Complementary Medicine Authors: NCCAM Source Type: news

Cystic Fibrosis: Meveol effective against Burkholderia Dolosa
The new generation of antimicrobial confirmed its potential with the evidence of effectiveness on this resistant bacterium kindly provided by Harvard Children's Hospital for which no therapeutic solution is available to date Apr 07, 2011 – Alaxia, a Lyons biotech that is developing the candidate drug Meveol hired an independent certified laboratory to confirm in vitro efficacy recorded by its microbiologists. The effect of Meveol has been studied on several strains of Burkholderia dolosa. Meveol bactericidal efficacy - over 99.9% - is observed in a few hours. These results were obtained as part of a research partn...
Source: Alaxia - April 7, 2011 Category: Respiratory Medicine Source Type: news

Efficacy also shown on Mycobacteria for Meveol
Further to some clinician request, Alaxia ordered an independant lab, CER in Belgium, to test Meveol efficacy vs atypical mycobacteria. Meveol shows high efficacy vs this strong pathogenic strain. We remind you Meveol is effective not only on Pseudomonas but on wide spectrum of bacteria including positive and negative gram Burkholderia, Pseudomonas even in biofilm form. (Source: Alaxia) (Source: Alaxia)
Source: Alaxia - June 28, 2010 Category: Respiratory Medicine Source Type: news

A new tool for Cystic Fibrosis
Alaxia announces today its product, meveol, has been tested successfully by an independant lab on strong strains including mucoid pseudomonas, burkholderia, MRSA both In Vitro and In Vivo Meveol targets to compensate natural host defence defective in cystic fibrosis (Source: Alaxia) (Source: Alaxia) (Source: Alaxia)
Source: Alaxia - March 27, 2009 Category: Respiratory Medicine Source Type: news

A new tool for Cystic Fibrosis
Alaxia announces today its product, meveol, has been tested successfully by an independant lab on strong strains including mucoid pseudomonas, burkholderia, MRSA both In Vitro and In Vivo Meveol targets to compensate natural host defence defective in cystic fibrosis (Source: Alaxia) (Source: Alaxia) (Source: Alaxia) (Source: Alaxia)
Source: Alaxia - March 27, 2009 Category: Respiratory Medicine Source Type: news

A new tool for Cystic Fibrosis
Alaxia announces today its product, meveol, has been tested successfully by an independant lab on strong strains including mucoid pseudomonas, burkholderia, MRSA both In Vitro and In Vivo Meveol targets to compensate natural host defence defective in cystic fibrosis (Source: Alaxia) (Source: Alaxia) (Source: Alaxia) (Source: Alaxia) (Source: Alaxia)
Source: Alaxia - March 27, 2009 Category: Respiratory Medicine Source Type: news